Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接:
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE189325
下载链接
链接失效反馈官方服务:
资源简介:
This SuperSeries is composed of the SubSeries listed below. Refer to individual Series
应用场景:
创建时间:
2023-03-08
相关数据集
Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts. Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem10
Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts [Bulk RNA-seq]. Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts [Bulk RNA-seq]
Aim: The goals of this study were to identify transcriptomic changes that arise in basal-like breast cancer cells during the development of resistance to epidermal growth factor receptor inhibitors (E
NIAID Data Ecosystem10
Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts [scRNA-seq]
Aim: The goals of this study were to identify transcriptomic changes that arise in basal-like breast cancer cells during the development of resistance to epidermal growth factor receptor inhibitors (E
NIAID Data Ecosystem10
Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts [scRNA-seq]. Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts [scRNA-seq]
Aim: The goals of this study were to identify transcriptomic changes that arise in basal-like breast cancer cells during the development of resistance to epidermal growth factor receptor inhibitors (E
NIAID Data Ecosystem10
Establishment of EGFR-inhibitor resistant triple negative breast cancer models from patient derived xenografts [scRNA-seq]
Aim: The goals of this study were to identify transcriptomic changes that arise in basal-like breast cancer cells during the development of resistance to epidermal growth factor receptor inhibitors (E
NIAID Data Ecosystem30



